Literature DB >> 22342254

Fibroblast growth factor signaling controlling bone formation: an update.

Pierre J Marie1.   

Abstract

Fibroblast Growth Factors (FGFs) regulate prenatal and postnatal bone formation through activation of FGF receptors (FGFR) and downstream signaling events. During the last decade, major advances have been made in our understanding of the mechanisms by which FGF/FGFR signaling controls osteoprogenitor cell replication and osteoblast differentiation and function. The analysis of the phenotype induced by FGF invalidation and mutations in FGFR allowed to delineate key FGF signaling pathways that regulate osteoblastogenesis. Molecular genomic studies led to identify target genes that are controlled by FGF/FGFR signaling and govern osteoblasts. The analysis of intracellular signaling pathways showed the importance of functional crosstalks between FGF signaling and other pathways in the regulation of bone formation. These recent progresses in the mechanisms underlying FGF/FGFR signaling may provide a molecular basis for developing therapeutic strategies in human skeletal dysplasias.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342254     DOI: 10.1016/j.gene.2012.01.086

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  30 in total

1.  Enhanced Dentinogenesis of Pulp Progenitors by Early Exposure to FGF2.

Authors:  K Sagomonyants; I Kalajzic; P Maye; M Mina
Journal:  J Dent Res       Date:  2015-08-14       Impact factor: 6.116

2.  Fibroblast growth factor-7 facilitates osteogenic differentiation of embryonic stem cells through the activation of ERK/Runx2 signaling.

Authors:  Young-Mi Jeon; Sung-Ho Kook; Sang-Jung Rho; Shin-Saeng Lim; Ki-Choon Choi; Hee-Soon Kim; Jong-Ghee Kim; Jeong-Chae Lee
Journal:  Mol Cell Biochem       Date:  2013-06-04       Impact factor: 3.396

3.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

4.  Low intensity pulsed ultrasound in the treatment of long bone nonunions: Evaluation of cytokine expression as a tool for objectifying nonunion therapy.

Authors:  Arash Moghaddam; Timur Mert Yildirim; Fabian Westhauser; Wolfgang Danner; Tyler Swing; Thomas Bruckner; Bahram Biglari
Journal:  J Orthop       Date:  2016-07-02

5.  Lentiviral arrays for live-cell dynamic monitoring of gene and pathway activity during stem cell differentiation.

Authors:  Roshan M Padmashali; Panagiotis Mistriotis; Mao-shih Liang; Stelios T Andreadis
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

6.  Stage-specific effects of fibroblast growth factor 2 on the differentiation of dental pulp cells.

Authors:  Karen Sagomonyants; Mina Mina
Journal:  Cells Tissues Organs       Date:  2015-03-25       Impact factor: 2.481

7.  Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23.

Authors:  Xiaobin Han; Zhousheng Xiao; L Darryl Quarles
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

8.  The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate/protein kinase Cδ cascade.

Authors:  Corinne Niger; Maria A Luciotti; Atum M Buo; Carla Hebert; Vy Ma; Joseph P Stains
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

Review 9.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

Review 10.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.